Submission Details
| 510(k) Number | K941624 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 04, 1994 |
| Decision Date | August 04, 1995 |
| Days to Decision | 487 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K941624 is an FDA 510(k) clearance for the RUBELLA IGG ELISA TEST, a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II — Special Controls, product code LFX), submitted by Gull Laboratories, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on August 4, 1995, 487 days after receiving the submission on April 4, 1994. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3510.
| 510(k) Number | K941624 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 04, 1994 |
| Decision Date | August 04, 1995 |
| Days to Decision | 487 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | LFX — Enzyme Linked Immunoabsorbent Assay, Rubella |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3510 |